Tyra Biosciences (TYRA) Shares Issued (2020 - 2026)

Tyra Biosciences (TYRA) reported Shares Issued of $147.9 million for Q1 2026, up 9898.08% quarter-over-quarter from -$1.5 million in Q4 2021.

Tyra Biosciences (TYRA) Shares Issued (2020 - 2026) Analysis & Trends

Tyra Biosciences has reported Shares Issued for 3 years, with the latest figure at $147.9 million in Q1 2026.

For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $147.9 million; the trailing twelve-month figure through Mar 2026 stood at $146.2 million (changed N/A YoY), and the FY2021 full-year result was $181.2 million, changed N/A from the prior year.
Shares Issued for Q1 2026 stood at $147.9 million, up from -$1.5 million in the prior quarter.
The five-year high for Shares Issued was $147.9 million in Q1 2026, with the low at $147.9 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	5.40 Mn
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	27.00 Mn
9	Abivax	90.15 Bn	90.15 Bn	-	26,927.15
10	Tyra Biosciences	1.67 Bn	1.67 Bn	-	147.85 Mn

Download Data